Nassif David W.
Insider CIK 1636975 · STDY EVP and CFO · AXGT Principal Financial Officer, Director · PHVS CFO / CLO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PHVS Pharvaris N.V. | S Sale | 2026-09-21 | 2026-09-23 | 6,000 | $36.47 | $218.8K | 114,300 | SEC↗ |
| PHVS Pharvaris N.V. | G Gift | 2026-09-21 | 2026-09-23 | 500 | — | $0 | 113,800 | SEC↗ |
| PHVS Pharvaris N.V. | G Gift | 2026-09-21 | 2026-09-23 | 500 | — | $0 | 113,800 | SEC↗ |
| PHVS Pharvaris N.V. | S Sale | 2026-09-21 | 2026-09-23 | 6,000 | $36.47 | $218.8K | 114,300 | SEC↗ |
| PHVS Pharvaris N.V. | S Sale | 2026-05-21 | 2026-05-26 | 10,000 | $30.31 | $303.1K | 120,300 | SEC↗ |
| SIOX Sio Gene Therapies Inc. | A Award deriv | 2022-02-08 | 2022-02-10 | 546,500 | — | $0 | 546,500 | SEC↗ |
| SIOX Sio Gene Therapies Inc. | D To issuer deriv | 2021-12-08 | 2021-12-09 | 17,534 | — | $0 | 35,066 | SEC↗ |
| SIOX Sio Gene Therapies Inc. | F Tax w/h | 2021-12-08 | 2021-12-09 | 6,294 | $1.42 | $8.9K | 45,244 | SEC↗ |
| SIOX Sio Gene Therapies Inc. | A Award | 2021-12-08 | 2021-12-09 | 17,534 | — | $0 | 51,538 | SEC↗ |
| SIOX Sio Gene Therapies Inc. | A Award deriv | 2021-04-15 | 2021-04-19 | 239,000 | — | $0 | 239,000 | SEC↗ |
| SIOX Sio Gene Therapies Inc. | D To issuer deriv | 2021-03-22 | 2021-03-22 | 15,060 | — | $0 | 0 | SEC↗ |
| SIOX Sio Gene Therapies Inc. | A Award | 2021-03-22 | 2021-03-22 | 15,060 | — | $0 | 34,004 | SEC↗ |
| AXGT Axovant Gene Therapies Ltd | D To issuer deriv | 2020-06-12 | 2020-06-15 | 15,060 | — | $0 | 15,060 | SEC↗ |
| AXGT Axovant Gene Therapies Ltd | A Award | 2020-06-11 | 2020-06-15 | 15,060 | — | $0 | 24,210 | SEC↗ |
| AXGT Axovant Gene Therapies Ltd | F Tax w/h | 2020-06-11 | 2020-06-15 | 5,266 | $3.25 | $17.1K | 18,944 | SEC↗ |
| AXGT Axovant Gene Therapies Ltd | A Award deriv | 2020-04-15 | 2020-04-17 | 78,900 | — | $0 | 78,900 | SEC↗ |
| AXGT Axovant Gene Therapies Ltd | A Award deriv | 2020-04-15 | 2020-04-17 | 52,600 | — | $0 | 52,600 | SEC↗ |
| AXGT Axovant Gene Therapies Ltd | A Award deriv | 2019-09-21 | 2019-09-24 | 30,120 | — | $0 | 30,120 | SEC↗ |
| AXGT Axovant Gene Therapies Ltd | A Award deriv | 2019-07-01 | 2019-07-02 | 75,000 | — | $0 | 75,000 | SEC↗ |
| AXGT Axovant Gene Therapies Ltd | A Award deriv | 2019-07-01 | 2019-07-02 | 150,000 | — | $0 | 150,000 | SEC↗ |
| STDY SteadyMed Ltd. | J Other deriv | 2018-08-30 | 2018-09-04 | 3,100 | — | $0 | 0 | SEC↗ |
| STDY SteadyMed Ltd. | J Other deriv | 2018-08-30 | 2018-09-04 | 159,642 | — | $0 | 0 | SEC↗ |
| STDY SteadyMed Ltd. | J Other deriv | 2018-08-30 | 2018-09-04 | 51,832 | — | $0 | 0 | SEC↗ |
| STDY SteadyMed Ltd. | J Other deriv | 2018-08-30 | 2018-09-04 | 40,000 | — | $0 | 0 | SEC↗ |
| STDY SteadyMed Ltd. | J Other deriv | 2018-08-30 | 2018-09-04 | 15,987 | — | $0 | 0 | SEC↗ |
| STDY SteadyMed Ltd. | S Sale | 2018-08-30 | 2018-09-04 | 22,157 | $4.46 | $98.8K | 0 | SEC↗ |
| STDY SteadyMed Ltd. | S Sale | 2018-07-05 | 2018-07-09 | 12,157 | $4.50 | $54.7K | 22,157 | SEC↗ |
| STDY SteadyMed Ltd. | S Sale | 2018-07-02 | 2018-07-03 | 10,001 | $4.50 | $45.0K | 34,314 | SEC↗ |
| STDY SteadyMed Ltd. | A Award deriv | 2017-12-28 | 2017-12-28 | 15,987 | — | $0 | 15,987 | SEC↗ |
| STDY SteadyMed Ltd. | A Award | 2017-11-13 | 2017-11-15 | 44,315 | — | $0 | 44,315 | SEC↗ |
| STDY SteadyMed Ltd. | A Award deriv | 2016-06-17 | 2016-07-22 | 40,000 | — | $0 | 40,000 | SEC↗ |